Price
2,947.7
-2.83%52W Range
Market Cap
₹1,821.10 Cr
Traded: ₹1.86 Cr (0.10%) 0.0x
Free Float: ₹495.88 Cr (0.37% of FF traded)
Volume · 60D trend
6.22 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +14.0% | +22.0% | -- | +36.0% | Accelerating |
| ROE | -- | +15.0% | +13.0% | -- | -- | Decelerating |
| Return | +27.0% | +11.0% | +22.0% | +113.0% | -- | Accelerating |
| Profit | -- | -3.0% | +33.0% | -- | +128.0% | Accelerating |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 139 | 149 | 128 | 120 | 104 | 95 | 89 | 93 | 91 | 100 | 88 | 80 | 71 | 75 | 72 | 68 |
| Expenses | 116 | 128 | 105 | 103 | 93 | 89 | 84 | 82 | 81 | 84 | 74 | 66 | 61 | 61 | 62 | 59 |
| Operating Profit | 23 | 21 | 22 | 17 | 11 | 6 | 5 | 12 | 9 | 16 | 14 | 14 | 10 | 14 | 10 | 9 |
| OPM % | 17.0% | 14.0% | 18.0% | 14.0% | 11.0% | 7.0% | 6.0% | 12.0% | 10.0% | 16.0% | 16.0% | 17.0% | 14.0% | 19.0% | 14.0% | 13.5% |
| Other Income | 7 | 2 | 5 | 2 | 6 | -1 | 0 | 5 | 6 | 4 | 4 | 3 | 3 | 1 | 1 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 5 | 5 | 5 | 5 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 1 | 3 |
| Profit Before Tax | 24 | 18 | 21 | 13 | 12 | 1 | 1 | 13 | 12 | 16 | 14 | 14 | 10 | 12 | 9 | 6 |
| Tax % | 25.0% | 24.0% | 24.0% | 26.0% | 22.0% | 49.0% | -1.0% | 26.0% | 22.0% | 23.0% | 30.0% | 25.0% | 16.0% | 23.0% | 28.0% | 25.4% |
| Net Profit | 18 | 13 | 16 | 10 | 9 | 1 | 1 | 10 | 9 | 12 | 10 | 10 | 9 | 9 | 6 | 5 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 29.8 | 21.8 | 25.4 | 15.6 | 15.0 | 0.9 | 2.1 | 15.9 | 14.9 | 19.9 | 16.2 | 17.0 | 13.8 | 15.1 | 10.5 | 7.6 |
| Sales Growth (YoY) | 33.6% | 57.1% | 43.1% | 28.6% | 14.8% | -4.8% | 1.3% | 16.6% | 27.7% | 32.8% | 22.3% | 18.4% | 8.9% | -- | -- | -- |
| Sales Growth (QoQ) | -- | 16.4% | 6.7% | 15.4% | 9.5% | 6.7% | -4.3% | 2.2% | -9.0% | 13.6% | 10.0% | 12.7% | -5.3% | 4.2% | 6.3% | -- |
| OP Growth (YoY) | 109.1% | 250.0% | 340.0% | 41.7% | 22.2% | -62.5% | -64.3% | -14.3% | -10.0% | 14.3% | 40.0% | 53.0% | -- | -- | -- | -- |
| OP Growth (QoQ) | 9.5% | -4.5% | 29.4% | 54.5% | 83.3% | 20.0% | -58.3% | 33.3% | -43.8% | 14.3% | 0.0% | 40.0% | -28.6% | 40.0% | 9.3% | -- |
| Profit Growth (YoY) | -- | 2398.0% | 1126.0% | -2.0% | 0.0% | -96.0% | -87.0% | -6.0% | 8.0% | 32.0% | 55.0% | 124.0% | 1537.0% | 36.0% | -35.0% | -66.4% |
| EPS Growth (YoY) | -- | 2410.3% | 1127.0% | -1.8% | 0.3% | -95.6% | -87.3% | -6.4% | 8.3% | 32.1% | 54.5% | 124.3% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | -14.0% | 62.9% | 4.2% | 1619.5% | -58.0% | -87.0% | 6.4% | -25.2% | 22.8% | -4.3% | 23.2% | -8.8% | 43.6% | 39.0% | -- |
| OP Margin | -- | 14.1% | 17.2% | 14.2% | 10.6% | 6.3% | 5.6% | 12.9% | 9.9% | 16.0% | 15.9% | 17.5% | 14.1% | 18.7% | 13.9% | 13.5% |
| Net Margin | -- | 8.7% | 12.5% | 8.3% | 8.7% | 1.1% | 1.1% | 10.8% | 9.9% | 12.0% | 11.4% | 12.5% | 12.7% | 12.0% | 8.3% | 6.9% |
| Material Cost % | 44.1% | 47.5% | 46.7% | 47.6% | 49.8% | 50.3% | 48.9% | 47.3% | 52.0% | 47.4% | 46.9% | 45.1% | 47.8% | 46.6% | 51.2% | 49.7% |
| Employee Cost % | 13.6% | 11.4% | 13.4% | 13.1% | 15.1% | 15.0% | 16.4% | 15.8% | 13.1% | 12.1% | 13.1% | 13.6% | 14.9% | 13.2% | 12.5% | 13.4% |
| P/S | 3.40 | 4.20 | 3.46 | 3.48 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 31.83 | 43.82 | 44.03 | 68.71 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 5.54 | 6.40 | 5.15 | 4.74 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Corrigendum to the 45th Annual Report for the Financial Year 2025-26
Investors Presentation - Q1FY27
Newspaper Publication of Financial Results for the quarter ended June 30, 2026.
Board comments on fines levied by the Exchanges
We wish to inform you that, the Board of Directors of the Company at their meeting held today i.e. on Wednesday, August 12, 2026 has inter-alia considered and approved the following: 1. ....
Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026.
NGL Fine Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited Standalone & Consolidated ....
Submission of Business Responsibility and Sustainability Reporting for FY 2025-26
Submission of Annual Report as per Reg. 34 (1)
Submission of Notice of 45 Annual General Meeting and Annual Report of the Company for the Financial Year 2025-26
Newspaper Advertisement - Notice to the Equity Shareholders of the Company Regarding Transfer of Equity Shares to Investor Education and Protection Fund
Certificate Under Reg. 74(5) of SEBI (DP) Regulations, 2018
Intimation of Closure of Trading Window
Transcript of the Earnings Call - Q4 & FY 26
Annual Secretarial Compliance Report for FY 2025-26
Audio Recording of Earning Conference Call Q4 & FY26
The Newspaper Advertisements of Financial Results for the quarter and year ended March 31, 2026, published in Free Press Journal ( English) and Navshakti ( Marathi) newspaper on Saturday, ....
Investors Presentation Q4 & FY26
19.08.2026 to 25.08.2026 (Both Days Inclusive)
The Record Date for the purpose of Annual General meeting and payment of final dividend is Tuesday, August 18, 2026
Outcome of Board Meeting
Audited Financial Results ( Standalone & Consolidated) Along with Statutory Auditor''s Report
Outcome of the Board Meeting held on Thursday, May 21, 2026
NGL Fine Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve Further to our communication ....
Intimation of schedule of Earning Conference Call to discuss Q4 & FY26 Results
NGL Fine Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve we wish to inform you that a ....
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026.
Intimation of Closure of Trading window
Intimation of revision in credit rating pursuant to Regulation 30 of SEBI (Listing Oblignation and Disclsoure Requirement) Regulations, 2015
Investors Presentation
Newspaper Advertisement - Financial Results
Outcome of Board Meeting - Appointment of Company Secretary and Compliance Officer
Outcome of Board Meeting
Outcome of Board Meetiong
NGL Fine Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve This is to inform you that the ....
Resignation of Company Secretary
Reg.74(5) submission
Trading Window Closure
Investor meet outcome
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015 and further to our intimation of Investor ....
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Mr. Rahul Nachane, Managing Director of the ....
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company participated in the Investors Conference Call ....
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company participated in the Investors Conference Call ....
Investor Presentation
Results for the quarter ended 30th September, 2025
This is to inform you that the third Meeting of the Board of Directors of NGL Fine-Chem Limited for the Financial Year 2025-2026 held on Wednesday, 12th November, 2025 at 301 E-Square, ....
Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company will hold ....
NGL Fine Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve This is to inform you that the ....
Certificate under Reg. 74(5) of SEBI (DP) Regulation, 2018
Scrutinizer''s Report for the Annual General Meeting
Annual Reports
15Credit Ratings
6Concalls
26Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024Jun 2024
30 Jun 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Nov 2021
30 Nov 2021Aug 2021
31 Aug 2021Jun 2021
30 Jun 2021Jun 2021
30 Jun 2021Nov 2020
30 Nov 2020Jul 2020
31 Jul 2020Dec 2019
31 Dec 2019